Lupin Launches VITALYFE to Transform Cardiometabolic Care

Lupin Launches VITALYFE to Transform Cardiometabolic Care

India Pharma Outlook Team | Friday, 31 October 2025

 Lupin Digital Health, VITALYFE

Lupin Digital Health, India’s leading cardiac digital-therapeutics company, has launched VITALYFE, an AI-powered cardiometabolic wellness platform designed to help India’s professionals improve their heart health.

Built on LYFE, India’s first CDSCO-approved Class C software medical device for cardiac care, the platform extends clinical expertise into preventive wellness.

India’s corporate workforce faces a growing cardiometabolic health crisis, with nearly 80% showing early signs of hypertension and dyslipidemia — both major contributors to premature heart aging. Long hours, stress, poor diet, and lack of sleep are accelerating heart risks among young professionals.

Also Read: Unlocking India's Innovation Potential in Pharma

“Cardiometabolic risks silently erode both health and productivity,” said Rajeev Sibal, president – India Region Formulations, Lupin. “With VITALYFE, we are enabling insurers and employers to combine clinical expertise with AI-driven technology to deliver scalable, measurable wellness outcomes for millions of working Indians.”

Using AI, behavioural science, and computer-vision technology, VITALYFE identifies early risks and offers personalized lifestyle guidance to slow heart aging. Available through insurers, brokers, and employers, it helps organizations include heart wellness in their employee benefits — improving well-being and reducing lifestyle-related claims.

“At Lupin Digital Health, we have seen how evidence-based digital therapeutics through LYFE have transformed cardiac recovery,” said Sidharth Srinivasan, chief executive officer – Lupin Digital Health. “With VITALYFE, we are extending that scientific foundation to a much larger audience — helping professionals understand their heart age, make better lifestyle choices, and literally make their hearts younger. Our vision is to make cardiometabolic wellness both measurable and mainstream.”

Compliant with India’s Digital Personal Data Protection (DPDP) Act and ISO 27001-certified, VITALYFE ensures secure, India-based data storage while promoting a healthier, more resilient workforce.

on the deck

Most Viewed

Related Articles


© 2025 India Pharma Outlook. All Rights Reserved.